GlassScriptPhysician profile
Kral Varhan
NPI 1235147919
$1,979.45
in general payments reported to CMS, 2019-2025
17 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $241 · 2021: $275 · 2022: $401 · 2023: $65.74 · 2024: $488 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $736.49 | 2019-2025 | Na, Tfn-Advance, Va-Lcp |
| Zimmer Biomet Holdings, INC. | $272.05 | 2021-2024 | |
| Carbofix Orthopedics INC | $200.05 | 2022-2024 | |
| Heron Therapeutics, INC. | $185.16 | 2021-2024 | Zynrelef |
| Cumberland Pharmaceuticals, INC. | $147.61 | 2022 | |
| Integra Lifesciences Corporation | $125.75 | 2020 | |
| Crossroads Orthopedics, LLC | $119.47 | 2022 | |
| Kerecis Limited | $30.50 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Novo Nordisk INC | $24.27 | 2025 | |
| Stryker Corporation | $22.85 | 2022 | |
| Bioventus LLC | $20.92 | 2022 | |
| Azurity Pharmaceuticals, INC. | $20.14 | 2025 | Horizant |
| Pacira Therapeutics, INC. | $17.41 | 2019 | |
| Orthofix Medical, INC. | $16.59 | 2025 | Physio-Stim |
| Avanos Medical | $14.55 | 2024 | On-Q* Pump and Accessories |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $14.00 | 2019 | |
| Heraeus Medical, LLC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kral Varhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.